← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Elsohly Laboratories, Inc.
Oxford, MS
$4,181,242
Total funding
13
Grants
Funding over time
peak $771.3K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,181,242 · 13
By mechanism
R42$2,041,264 · 3
R41$936,146 · 6
N44$682,137 · 1
R21$427,879 · 1
R43$93,816 · 1
N43$0 · 1
Investigators at Elsohly Laboratories, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
DEVELO[ AN ECONOMIC SUPPLY OF DELTA 9 THC$682,137
N44 · FY2000 · DA
Transmucosal Intra-Oral Drug Delivery System for THC$398,915
R42 · FY2009 · GM
Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis$372,404
R42 · FY2009 · AR
Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis$366,814
R42 · FY2010 · AR
Transmucosal Intra-Oral Drug Delivery System for THC$344,694
R42 · FY2008 · GM
DEVELOPMENT OF A NEW DRUG FOR P. CARINII AND MALARIA$276,333
R42 · FY2000 · AI
Isolation and Pharmacological Evaluation of Impurities in Î-8-THC Products$228,967
R21 · FY2025 · DA
Transmucosal Intra-Oral Drug Delivery System for THC$213,604
R42 · FY2010 · GM
Orally Active Formulations of DHA Dimers for the Treatment of Infectious Diseases$205,514
R41 · FY2013 · AI
Isolation and Pharmacological Evaluation of Impurities in Î-8-THC Products$198,912
R21 · FY2024 · DA
Development of a Process for GMP Production of Natural THC and CBD$182,361
R41 · FY2019 · DA
An Opioid/Cannabinoid Analgesic that Boosts Pain Relief and Blocks Opiate Reward$180,830
R41 · FY2018 · DA
Development of Tetrahydrocannabinol Prodrugs for Topical Treatment of Glaucoma$167,381
R41 · FY2011 · EY
Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis$100,074
R41 · FY2006 · AR
Transmucosal Intra-Oral Drug Delivery System for THC$99,986
R41 · FY2003 · GM
Synthesis of Conjugated Metabolites of Buprenophine$93,816
R43 · FY2002 · DA
PRECLINICAL DEVELOP. OF A NEW DRUG FOR PCP AND MALARIA$68,500
R42 · FY2001 · AI
DEVELOPMENT OF AN ECONOMIC SUPPLY OF DELTA-9-THC$0
N43 · FY2000 · DA